Page 2 - Daniel Vitt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

Immunic Inc CEO Dr Daniel Vitt joined Proactive s Stephen Gunnion with news of the publication of extended data from the Phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting.

United statesDaniel vittStephen gunnionNeuroimmunology neuroinflammationAmerican academy of neurologyImmunic inc

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesNeuroimmunology neuroinflammationStephen gunnionDaniel vittImmunic incAmerican academy of neurologyAmerican academy

Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role

Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Stephen gunnionDaniel vittInternational day of immunologyImmunic incInternational day

Lower vidofludimus calcium dose not as effective in RMMS trial

Lower vidofludimus calcium dose not as effective in RMMS trial
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Andreas muehlerDaniel vittVidofludimus calciumRelapsing multiple sclerosisExtended resultsPlacebo controlled phaseImmunic therapeuticsMultiple sclerosis news

EQS-News: Immunic AG: Immunic to Host MS R&D Day and Participate in Investor Conferences in April

EQS-News: Immunic AG: Immunic to Host MS R&D Day and Participate in Investor Conferences in April
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomSan franciscoUnited statesDaniel vittJessica breuPaula schwartzEdna kaplanDennis riedlAndreas muehlerHella kohlhofSclerosis ms researchDistribution servicesRx communications groupDevelopment rd dayHotel nikkoImmunic inc